[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News & Perspectives
April 17, 2002

Peptides Prove Predictive for Heart Failure Patients

Author Affiliations
 

Not Available

Not Available

JAMA. 2002;287(15):1926-1929. doi:10.1001/jama.287.15.1926-JMN0417-3-1

Atlanta—Researchers speaking at the American College of Cardiology meeting here last month said the measurement of B-type natriuretic peptide (BNP) in patients thought to have congestive heart failure (CHF) has high diagnostic accuracy and should be included in US treatment guidelines for the disease, as it is in European ones.

Peter A. McCullough, MD, chief of cardiology at the University of Missouri–Kansas City School of Medicine, said that there is an epidemic of CHF in the United States: about 5 million Americans have the disease and 500 000 new cases are reported annually.

First Page Preview View Large
First page PDF preview
First page PDF preview
×